- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 11/00 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
Patent holdings for IPC class C07K 11/00
Total number of patents in this class: 109
10-year publication summary
11
|
6
|
6
|
7
|
10
|
11
|
10
|
5
|
3
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Onkure, Inc. | 21 |
5 |
Board of Regents, The University of Texas System | 5370 |
3 |
President and Fellows of Harvard College | 5792 |
3 |
Sanofi | 3836 |
3 |
Novartis AG | 11238 |
2 |
The Regents of the University of California | 18943 |
2 |
Massachusetts Institute of Technology | 9795 |
2 |
Agency for Science, Technology and Research | 3512 |
2 |
University of Florida Research Foundation, Inc. | 3883 |
2 |
The Broad Institute, Inc. | 1584 |
2 |
Karus Therapeutics Limited | 28 |
2 |
Nanyang Technological University | 1739 |
2 |
National University Corporation Gunma University | 306 |
2 |
Osaka Prefecture University Public Corporation | 252 |
2 |
The Regents of the University of Colorado, a body corporate | 2430 |
2 |
Shenzhen Institutes of Advanced Technology | 1177 |
2 |
Stella Pharma Corporation | 36 |
2 |
University of Vermont and State Agricultural College | 373 |
2 |
The USA, as represented by the Secretary, Dept. of Health and Human Services | 80 |
2 |
Aesculus Bio ApS | 5 |
2 |
Other owners | 63 |